HomeNewsBusinesscommoditiesOPEC+ maintains modest monthly increases in oil output

OPEC+ maintains modest monthly increases in oil output

The OPEC+ alliance approved an increase in production of 400,000 barrels per day for the month of January at a meeting.

December 02, 2021 / 20:58 IST
Story continues below Advertisement
Representative image | Source: Reuters
Representative image | Source: Reuters

OPEC and allied oil-producing countries have decided to maintain the amount of oil they pump to the world even as the new omicron variant casts a spikey shadow of uncertainty over the global economic recovery from the coronavirus pandemic.

Officials from OPEC countries, led by Saudi Arabia, and their allies, led by Russia, voted Thursday to stick with a pre-omicron pattern of steady, modest monthly increases in oil releases — a pace that has frustrated the United States and other oil-consuming nations as gasoline prices rise. The OPEC+ alliance approved an increase in production of 400,000 barrels per day for the month of January at a meeting.

Story continues below Advertisement

ALSO READ: Oil rallies as OPEC meets, but supply glut looms

The fast-mutating variant led countries to impose barriers to travel when it emerged late last week. Americans had been celebrating what seemed to be a nearly normal Thanksgiving after some pandemic restrictions eased.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show